Isda launches CDS protocols for Icelandic bank settlement

Isda is providing protocols to amend CDS paperwork before the settlement auctions for Iceland’s defaulted banks

LONDON & NEW YORK – The International Swaps and Derivatives Association (Isda) has released credit default swap (CDS) settlement protocols for failed Icelandic banks Glitnir, Kaupthing and Landsbanki.

Around $71 billion in CDS contracts on the three banks must be settled, according to the New York-based Depository Trust & Clearing Corporation (DTCC). This is split between $19.2 billion outstanding on Landsbanki, $18.5 billion on Glitnir and $34.3 billion on Kaupthing.

After netting down protections bought and sold by the same big players – which has reportedly successfully limited exposure to Lehman CDS counterparties – actual exposures might be around $14.8 billion, says the DTCC.

The new protocols aim to offer affected counterparties an efficient mechanism for the settlement of credit derivatives transactions. They offer institutions the opportunity to amend documentation to use auctions, scheduled by administrators Markit and Creditex for November 4, 5 and 6, to settle contracts referencing the three defaulted institutions.

David Geen, general counsel for Isda, said: “These are the first credit events to occur in the European market since Isda started publishing protocols for settlement. The experience of running these protocols successfully for over a dozen North American credit events will be of enormous benefit in ensuring the process runs equally smoothly in Europe.”

The Isda protocols are available until October 31 and are open to members and non-members alike.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here